Skip to main content icon/video/no-internet

JOHNS HOPKINS UNIVERSITY (1876) is a private university located in Baltimore, Maryland. Johns Hopkins offers both undergraduate and graduate programs and was the first university in the United States to emphasize research in education. The mission of Hopkins is “The encouragement of research … and the advancement of individual scholars, who by their excellence will advance the sciences they pursue, and the society where they dwell.” Johns Hopkins, in fact, was a model for most large research universities throughout the United States.

The university boasts 32 Nobel laureates and is academically strong in every discipline, from art history to biomédical engineering to international studies to romantic languages.

Johns Hopkins used $1.44 billion in science, medical, and engineering research in the 2005 fiscal year, which made it the leading U.S. academic institution in research and development spending. The National Science Foundation ranked Johns Hopkins as number one on the list of institutions receiving federally funded research and development, which for Johns Hopkins amounted to over $1.2 billion. Research at Johns Hopkins on stem cells is supported by the National Institutes of Health (NIH), healthcare organizations, partnerships with corporations, and private donors.

At Johns Hopkins, undergraduate students are expected and encouraged to become involved with undergraduate research. In this respect, some undergraduate students have the opportunity to work alongside graduate students, postdoctoral fellows, and leading professionals in science to study stem cells in a laboratory setting. Johns Hopkins is also renowned for its academic healthcare centers and its graduate schools of medicine, public health, and international studies. The Johns Hopkins Hospital was ranked as the top hospital in the United States in the U.S. News and World Report annual ranking of American hospitals for the 17th year in a row; the medical school ranked second in the nation.

Current Stem Cell Research

Johns Hopkins explains in its publications that one of the greatest discoveries made in medicine was the potential of a single, undifferentiated cell; Johns Hopkins has noted in several instances that the use of a single, undifferentiated cell could be used in the future to address disease, pain, and cancer. The university, along with other organizations and institutions, also realizes that stem cell research raises ethical concerns and that policy and politics on stem cell research must be carefully regulated and balanced by science and medicine. Researchers at Johns Hopkins, and around the globe, are excited about the potential of the stem cell and the prospects of its use as a medical therapy in the future.

John Gearhart of Johns Hopkins discovered that a type of pluripotent stem cell could be isolated from human gonadal tissues in 1998. This stem cell (the embryonic germ cell) seemed similar to human embryonic stem cells discovered in the same year by Dr. James Thomson at the University of Wisconsin, Madison. However, over the years the embryonic germ cell has not gained widespread use in the scientific community.

Johns Hopkins believes that the use of stem cells for the promotion of human health and lifestyle should be the focus of biomédical experimentation and understanding. Hopkins supports the use of the somatic cell nuclear transferring technique (research cloning) to produce stem cell lines that are genetically identical to the parent cell; the stem cell lines, although controversial for some, give researchers a tool that will allow them to understand the development and progression of the cell and of disease and to predict what sorts of therapies could be used to treat disease and injury.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading